In recent years, prenatal genetic screening tests have gained popularity among expectant parents seeking early insight into their baby’s health. These noninvasive tests, particularly Noninvasive Prenatal Screening (NIPS), offer a seemingly straightforward way to assess the risk of chromosomal conditions such as Down syndrome during the first trimester of pregnancy. However, the growing reliance on